HIGH-YIELD PRINCIPLES IN

Public Health Sciences

“Medicine is a science of uncertainty and an art of probability.” ` Epidemiology and

—Sir William Osler Biostatistics 258

“Whenever a doctor cannot do good, he must be kept from doing harm.” ` Ethics 268
—Hippocrates
` Communication
“On a long enough timeline, the survival rate for everyone drops to zero.” Skills 271
—Chuck Palahniuk, Fight Club
` Healthcare Delivery 276
“Of all forms of discrimination and inequalities, injustice in health is the
most shocking and inhuman.” ` Quality and Safety 278
—Martin Luther King, Jr.

A heterogenous mix of epidemiology, biostatistics, ethics, law, healthcare

delivery, patient safety, quality improvement, and more falls under the
heading of public health sciences. Biostatistics and epidemiology are the
foundations of evidence-based medicine and are very high yield. Make
sure you can quickly apply biostatistical equations such as sensitivity,
specificity, and predictive values in a problem-solving format. Also,
know how to set up your own 2 × 2 tables, and beware questions that
switch the columns. Quality improvement and patient safety topics were
introduced a few years ago on the exam and represent trends in health
system science. Medical ethics questions often require application of
principles. Typically, you are presented with a patient scenario and then
asked how you would respond. In this edition, we provide further details
on communication skills and patient care given their growing emphasis
on the exam. Effective communication is essential to the physician-
patient partnership. Physicians must seek opportunities to connect with
patients, understand their perspectives, express empathy, and form
shared decisions and realistic goals.

257

FAS1_2022_06-PubHealth.indd 257 11/9/21 1:12 PM

 258 SECTION II Public Health Sciences   PUBLIC HEALTH SCIENCES—Epidemiology and Biostatistics

` PUBLIC HEALTH SCIENCES—EPIDEMIOLOGY AND BIOSTATISTICS

Observational studies
STUDY TYPE DESIGN MEASURES/EXAMPLE
Case series Describes several individual patients with the Description of clinical findings and symptoms.
same diagnosis, treatment, or outcome. Has no comparison group, thus cannot show
risk factor association with disease.
Cross-sectional study Frequency of disease and frequency of risk- Disease prevalence.
related factors are assessed in the present. Can show risk factor association with disease,
Asks, “What is happening?” but does not establish causality.
Case-control study Retrospectively compares a group of people with Odds ratio (OR).
disease to a group without disease. Control the case in the OR.
Looks to see if odds of prior exposure or risk Patients with COPD had higher odds of a
factor differ by disease state. smoking history than those without COPD.
Asks, “What happened?”
Cohort study Compares a group with a given exposure or risk Disease incidence.
factor to a group without such exposure. Relative risk (RR).
Looks to see if exposure or risk factor is People who smoke had a higher risk of
associated with later development of disease. developing COPD than people who do not.
Can be prospective or retrospective, but risk Cohort = relative risk.
factor has to be present prior to disease
development.
Twin concordance Compares the frequency with which both Measures heritability and influence of
study monozygotic twins vs both dizygotic twins environmental factors (“nature vs nurture”).
develop the same disease.
Adoption study Compares siblings raised by biological vs Measures heritability and influence of
adoptive parents. environmental factors.
Ecological study Compares frequency of disease and frequency Used to monitor population health.
of risk-related factors across populations. COPD prevalence was higher in more polluted
Measures population data not necessarily cities.
applicable to individuals (ecological fallacy).
Cross-sectional study Case-control study Retrospective cohort study Prospective cohort study

Compare risk factor

Past

frequency Risk factor Risk factor

Controls Compare disease

Risk factor Risk factor Diseased
without incidence
Present

cases Risk factor Risk factor

disease
Compare disease Review previous
prevalence records
Future

Compare disease
incidence

FAS1_2022_06-PubHealth.indd 258 11/9/21 1:13 PM